Raju Prasad - Mar 14, 2023 Form 3 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Chief Financial Officer
Signature: /s/ Elizabeth Ryland Waldinger
Stock symbol: CRSP
Transactions as of: Mar 14, 2023
Transactions value $: $0
Form type: 3
Date filed: 3/14/2023, 05:42 PM
Next filing: Oct 17, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney No securities are beneficially owned.